ID   MCF7-h14
AC   CVCL_VR08
DR   cancercelllines; CVCL_VR08
DR   Wikidata; Q95986791
RX   CelloPub=CLPUB00443;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; 4421; GNRHR.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 10-09-24; Version: 10
//
RX   CelloPub=CLPUB00443;
RA   Meyer C.;
RT   "Characterisation of the direct antiproliferative effects of a
RT   gonadotrophin-releasing hormone analogue.";
RL   Thesis PhD (2012); University of Edinburgh; Edinburgh; United Kingdom.
//